What is the recommended duration of sertraline (Selective Serotonin Reuptake Inhibitor) treatment for depression?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Duration of Sertraline Treatment for Depression

For patients with a first episode of major depressive disorder, sertraline treatment should be continued for 4-9 months after achieving remission, while patients with recurrent depression (2 or more episodes) should receive treatment for 2 years or longer to prevent relapse. 1, 2

Treatment Duration Based on Depression History

The recommended duration of sertraline treatment varies depending on the patient's history of depression:

  • First episode of depression:

    • Continue treatment for 4-9 months after achieving remission 2, 1
    • This continuation phase is critical to prevent relapse of the same depressive episode
  • Recurrent depression (2+ episodes):

    • Continue treatment for 2 years or longer 1
    • Risk of recurrence increases with each episode (50% after first episode, 70% after second episode, 90% after third episode) 2

Treatment Phases

The American College of Physicians defines three distinct phases of depression treatment 1:

  1. Acute Phase (6-12 weeks):

    • Initial treatment period focused on achieving response
    • Start with 50 mg daily, can increase to maximum 200 mg daily if needed 3
    • Dose changes should not occur at intervals less than 1 week 3
  2. Continuation Phase (4-9 months):

    • Prevents relapse of the same depressive episode
    • Maintain effective dose established during acute phase
  3. Maintenance Phase (≥1 year or longer):

    • Prevents recurrence of new episodes
    • Particularly important for patients with multiple previous episodes

Monitoring and Assessment

  • Begin assessment within 1-2 weeks of starting sertraline 2, 1
  • Evaluate therapeutic response at 4 weeks, then every 3 months if stable 1
  • Close monitoring is especially important during the first week of treatment due to increased suicide risk 1
  • If inadequate response occurs within 6-8 weeks, treatment modification is recommended 2, 1

Important Considerations

  • Although most clinical studies of antidepressants last one year or less, over 60% of Americans on antidepressants take them for more than two years 2
  • Systematic reviews show that continued treatment with antidepressants after remission protects against recurrence and relapse 2
  • The FDA label for sertraline notes that maintenance treatment beyond the acute response phase has demonstrated efficacy for up to 44 weeks following 8 weeks of initial treatment 3

Dosing Information

  • Initial dose: 50 mg once daily 3, 4
  • Can be increased in 50 mg increments at intervals of not less than one week 3
  • Maximum dose: 200 mg daily 3
  • 50 mg daily is the optimal dose for most patients, balancing efficacy and tolerability 4
  • Can be administered at any time of day 3, 4
  • No dose adjustments needed for elderly patients based solely on age 5

Remember that discontinuing sertraline abruptly can lead to withdrawal symptoms. When ending treatment, the dose should be gradually tapered to minimize this risk.

References

Guideline

Treatment of Depression

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Sertraline 50 mg daily: the optimal dose in the treatment of depression.

International clinical psychopharmacology, 1995

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.